Physician profile
John Bell
NPI 1235517202
$34,174.63
in general payments reported to CMS, 2019-2025
13 companies · $386 in 2025
The $386 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $31K · 2021: $1,471 · 2022: $1,244 · 2023: $18.78 · 2024: $16.73 · 2025: $386.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $422.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $421.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $20,000.00 | 2020 | |
| Smith+Nephew, INC. | $9,777.87 | 2020 | |
| Alon Medical Technology | $2,460.29 | 2020-2021 | |
| Peerless Surgical INC. | $1,340.47 | 2021-2022 | |
| Abiomed | $230.01 | 2025 | |
| Stryker Corporation | $157.00 | 2021 | |
| Depuy Synthes Sales INC. | $63.26 | 2025 | Monovisc, Orthovisc, Healix Knotless Peek |
| Abbvie INC. | $37.41 | 2024-2025 | |
| Innovation Technologies INC | $27.82 | 2025 | Irrisept |
| Vertex Pharmaceuticals Incorporated | $27.15 | 2025 | |
| Bioventus LLC | $18.78 | 2023 | Exogen Ultrasound Bone Healing System |
| Pacira Pharmaceuticals Incorporated | $17.42 | 2025 | Iovera, Zilretta |
| Boston Scientific Corporation | $17.15 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Bell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.